Skip to main content
Clinical Trials/ACTRN12612001213831
ACTRN12612001213831
Completed
Phase 1

A randomised placebo controlled crossover trial to evaluate the effects of intrajejunal taurocholic acid on gastrointestinal hormone secretion and glycaemia in response to intrajejunal glucose infusion in healthy humans for the future design of treatments for type 2 diabetes mellitus

Royal Adelaide Hospital0 sites14 target enrollmentNovember 16, 2012

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
Royal Adelaide Hospital
Enrollment
14
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 16, 2012
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
Male

Investigators

Eligibility Criteria

Inclusion Criteria

  • Healthy subjects; Body mass index (BMI) 19 \- 30 kg/m2; Haemoglobin \> 135 g/

Exclusion Criteria

  • Medications affecting gut function; Alcohol intake \>20g daily or cigarette smoking; Significant gastrointestinal disease or surgery; Impaired liver or renal function; Blood donation within 3 months

Outcomes

Primary Outcomes

Not specified

Similar Trials